Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 t cells

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1029-1042

  Wang, Hong ^a   Henry, Olivier ^b   Distefano, Mark D ^b   Wang, Yen Chih ^b   Raikkonen, Johanna ^c   Monkkonen, Jukka ^c   Tanaka, Yoshimasa ^d   Morita, Craig T ^a,e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d NAGASAKI UNIVERSITY   (Japan)

^e DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHYLBUT 2 ENYL PYROPHOSPHATE; BUTYROPHILIN 3A1; BUTYROPHILIN 3A2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; INTERLEUKIN 2; ISOPENTENYL DIPHOSPHATE; MONOCLONAL ANTIBODY; PRENYL PYROPHOSPHATE; PYROPHOSPHATE; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BABOON; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR BINDING; RHESUS MONKEY; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BINDING SITES, ANTIBODY; CELL LINE; HELA CELLS; HEMITERPENES; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; ORGANOPHOSPHORUS COMPOUNDS; PAPIO; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; T-LYMPHOCYTES; TERPENES;

EID: 84880647732     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300658     Document Type: Article

References (78)

1. Morita, C. T., C. Jin, G. Sarikonda, and H. Wang. 2007. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vg2Vd2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215: 59-76.
2. Hintz, M., A. Reichenberg, B. Altincicek, U. Bahr, R. M. Gschwind, A.-K. Kollas, E. Beck, J. Wiesner, M. Eberl, and H. Jomaa. 2001. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gd T cells in Escherichia coli. FEBS Lett. 509: 317-322.
3. Puan, K.-J., C. Jin, H. Wang, G. Sarikonda, A. M. Raker, H. K. Lee, M. I. Samuelson, E. Märker-Hermann, L. Pasa-Tolic, E. Nieves, et al. 2007. Preferential recognition of a microbial metabolite by human Vg2Vd2 T cells. Int. Immunol. 19: 657-673.
4. Kunzmann, V., E. Bauer, and M. Wilhelm. 1999. g/d T-cell stimulation by pamidronate. N. Engl. J. Med. 340: 737-738.
5. Gober, H.-J., M. Kistowska, L. Angman, P. Jenö, L. Mori, and G. De Libero. 2003. Human T cell receptor gd cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197: 163-168.
6. Thompson, K., and M. J. Rogers. 2004. Statins prevent bisphosphonateinduced g,d-T-cell proliferation and activation in vitro. J. Bone Miner. Res. 19: 278-288.
7. Sanders, J. M., S. Ghosh, J. M. W. Chan, G. Meints, H. Wang, A. M. Raker, Y. Song, A. Colantino, A. Burzynska, P. Kafarski, et al. 2004. Quantitative structure-Activity relationships for gd T cell activation by bisphosphonates. J. Med. Chem. 47: 375-384.
8. Wang, H., G. Sarikonda, K.-J. Puan, Y. Tanaka, J. Feng, J.-L. Giner, R. Cao, J. Mönkkönen, E. Oldfield, and C. T. Morita. 2011. Indirect stimulation of human Vg2Vd2 T cells through alterations in isoprenoid metabolism. J. Immunol. 187: 5099-5113.
9. Bukowski, J. F., C. T. Morita, and M. B. Brenner. 1999. Human gd T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 11: 57-65.
10. Thompson, K., J. Rojas-Navea, and M. J. Rogers. 2006. Alkylamines cause Vg9Vd2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood 107: 651-654.
11. Morita, C. T., E. M. Beckman, J. F. Bukowski, Y. Tanaka, H. Band, B. R. Bloom, D. E. Golan, and M. B. Brenner. 1995. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gd T cells. Immunity 3: 495-507.
12. Lang, F., M. A. Peyrat, P. Constant, F. Davodeau, J. David-Ameline, Y. Poquet, H. Vié, J. J. Fournié, and M. Bonneville. 1995. Early activation of human Vg9Vd2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 154: 5986-5994.
13. Brandes, M., K. Willimann, and B. Moser. 2005. Professional antigenpresentation function by human gd T cells. Science 309: 264-268.
14. Morita, C. T., H. Li, J. G. Lamphear, R. R. Rich, J. D. Fraser, R. A. Mariuzza, and H. K. Lee. 2001. Superantigen recognition by gd T cells: SEA recognition site for human Vg2 T cell receptors. Immunity 14: 331-344.
15. Kato, Y., Y. Tanaka, H. Tanaka, S. Yamashita, and N. Minato. 2003. Requirement of species-specific interactions for the activation of human gd T cells by pamidronate. J. Immunol. 170: 3608-3613.
16. Sarikonda, G., H. Wang, K.-J. Puan, X.-H. Liu, H. K. Lee, Y. Song, M. D. Distefano, E. Oldfield, G. D. Prestwich, and C. T. Morita. 2008. Photoaffinity antigens for human gd T cells. J. Immunol. 181: 7738-7750.
17. Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. Vg2Vd2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154: 998-1006.
18. Allison, T. J., C. C. Winter, J. J. Fournié, M. Bonneville, and D. N. Garboczi. 2001. Structure of a human gd T-cell antigen receptor. Nature 411: 820-824.
19. Bukowski, J. F., C. T. Morita, H. Band, and M. B. Brenner. 1998. Crucial role of TCRg chain junctional region in prenyl pyrophosphate antigen recognition by gd T cells. J. Immunol. 161: 286-293.
20. Yamashita, S., Y. Tanaka, M. Harazaki, B. Mikami, and N. Minato. 2003. Recognition mechanism of non-peptide antigens by human gd T cells. Int. Immunol. 15: 1301-1307.
21. Miyagawa, F., Y. Tanaka, S. Yamashita, B. Mikami, K. Danno, M. Uehara, and N. Minato. 2001. Essential contribution of germline-encoded lysine residues in Jg1.2 segment to the recognition of nonpeptide antigens by human gd T cells. J. Immunol. 167: 6773-6779.
22. Morita, C. T., H. K. Lee, H. Wang, H. Li, R. A. Mariuzza, and Y. Tanaka. 2001. Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gd T cells. J. Immunol. 167: 36-41.
23. Wang, H., Z. Fang, and C. T. Morita. 2010. Vg2Vd2 T cell receptor recognition of prenyl pyrophosphates is dependent on all CDRs. J. Immunol. 184: 6209-6222.
24. Wei, H., D. Huang, X. Lai, M. Chen, W. Zhong, R. Wang, and Z. W. Chen. 2008. Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl- but-2-enyl pyrophosphate to Vg2Vd2 TCR. J. Immunol. 181: 4798-4806.
25. Harly, C., Y. Guillaume, S. Nedellec, C.-M. Peigné, H. Mönkkönen, J. Mönkkönen, J. Li, J. Kuball, E. J. Adams, S. Netzer, et al. 2012. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human gd T-cell subset. Blood 120: 2269-2279.
26. Palakodeti, A., A. Sandstrom, L. Sundaresan, C. Harly, S. Nedellec, D. Olive, E. Scotet, M. Bonneville, and E. J. Adams. 2012. The molecular basis for modulation of human Vg9Vd2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. J. Biol. Chem. 287: 32780-32790.
27. Abeler-Dörner, L., M. Swamy, G. Williams, A. C. Hayday, and A. Bas. 2012. Butyrophilins: an emerging family of immune regulators. Trends Immunol. 33: 34-41.
28. Compte, E., P. Pontarotti, Y. Collette, M. Lopez, and D. Olive. 2004. Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells. Eur. J. Immunol. 34: 2089-2099.
29. Morita, C. T., C.M. Parker, M. B. Brenner, and H. Band. 1994. TCR usage and functional capabilities of human gd T cells at birth. J. Immunol. 153: 3979-3988.
30. Morita, C. T., S. Verma, P. Aparicio, C. Martinez, H. Spits, and M. B. Brenner. 1991. Functionally distinct subsets of human g/d T cells. Eur. J. Immunol. 21: 2999-3007.
31. Spits, H., X. Paliard, Y. Vandekerckhove, P. van Vlasselaer, and J. E. de Vries. 1991. Functional and phenotypic differences between CD4+ and CD4-T cell receptor-gd clones from peripheral blood. J. Immunol. 147: 1180-1188.
32. Tanaka, Y., S. Sano, E. Nieves, G. De Libero, D. Rosa, R. L. Modlin, M. B. Brenner, B. R. Bloom, and C. T. Morita. 1994. Nonpeptide ligands for human gd T cells. Proc. Natl. Acad. Sci. USA 91: 8175-8179.
33. Wang, H., H. K. Lee, J. F. Bukowski, H. Li, R. A. Mariuzza, Z. W. Chen, K.-H. Nam, and C. T. Morita. 2003. Conservation of nonpeptide antigen recognition by rhesus monkey Vg2Vd2 T cells. J. Immunol. 170: 3696-3706.
34. Jauhiainen, M., H. Mönkkönen, J. Räikkönen, J. Mönkkönen, and S. Auriola. 2009. Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2967-2975.
35. Baker, N. A., D. Sept, S. Joseph, M. J. Holst, and J. A. McCammon. 2001. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 98: 10037-10041.
36. Dolinsky, T. J., P. Czodrowski, H. Li, J. E. Nielsen, J. H. Jensen, G. Klebe, and N. A. Baker. 2007. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 35(Web Server issue): W522-W525.
37. Spada, F. M., E. P. Grant, P. J. Peters, M. Sugita, A. Melián, D. S. Leslie, H. K. Lee, E. van Donselaar, D. A. Hanson, A. M. Krensky, et al. 2000. Selfrecognition of CD1 by g/d T cells: implications for innate immunity. J. Exp. Med. 191: 937-948.
38. Zhang, Y., R. Cao, F. Yin, F. Y. Lin, H. Wang, K. Krysiak, J. H. No, D. Mukkamala, K. Houlihan, J. Li, et al. 2010. Lipophilic pyridinium bisphosphonates: potent gd T cell stimulators. Angew. Chem. Int. Ed. Engl. 49: 1136-1138.
39. Roque, A. C., and C. R. Lowe. 2005. Lessons from nature: on the molecular recognition elements of the phosphoprotein binding-domains. Biotechnol. Bioeng. 91: 546-555.
40. Chen, A., P. A. Kroon, and C. D. Poulter. 1994. Isoprenyl diphosphate synthases: protein sequence comparisons, a phylogenetic tree, and predictions of secondary structure. Protein Sci. 3: 600-607.
41. Oldfield, E., and F. Y. Lin. 2012. Terpene biosynthesis: modularity rules. Angew. Chem. Int. Ed. Engl. 51: 1124-1137.
42. Sicard, H., S. Ingoure, B. Luciani, C. Serraz, J.-J. Fournié, M. Bonneville, J. Tiollier, and F. Romagné. 2005. In vivo immunomanipulation of Vg9Vd2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 175: 5471-5480.
43. Sturm, E., R. E. Bontrop, R. J. Vreugdenhil, N. Otting, and R. L. Bolhuis. 1992. T-cell receptor g/d: comparison of gene configurations and function between humans and chimpanzees. Immunogenetics 36: 294-301.
44. Daubenberger, C. A., M. Salomon, W. Vecino, B. Hübner, H. Troll, R. Rodriques, M. E. Patarroyo, and G. Pluschke. 2001. Functional and structural similarity of Vg9Vd2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J. Immunol. 167: 6421-6430.
45. Shen, Y., D. Zhou, L. Qiu, X. Lai, M. Simon, L. Shen, Z. Kou, Q. Wang, L. Jiang, J. Estep, et al. 2002. Adaptive immune response of Vg2Vd2+ T cells during mycobacterial infections. Science 295: 2255-2258.
46. Ryan-Payseur, B., J. Frencher, L. Shen, C. Y. Chen, D. Huang, and Z. W. Chen. 2012. Multieffector-functional immune responses of HMBPP-specific Vg2Vd2 T cells in nonhuman primates inoculated with Listeria monocytogenes DactA prfA. J. Immunol. 189: 1285-1293.
47. Kumar, S., and S. B. Hedges. 1998. A molecular timescale for vertebrate evolution. Nature 392: 917-920.
48. Cubillos-Ruiz, J. R., D. Martinez, U. K. Scarlett, M. R. Rutkowski, Y. C. Nesbeth, A. L. Camposećo-Jacobs, and J. R. Conejo-Garcia. 2010. CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. Oncotarget 1: 329-338.
49. Yamashiro, H., S. Yoshizaki, T. Tadaki, K. Egawa, and N. Seo. 2010. Stimulation of human butyrophilin 3 molecules results in negative regulation of cellular immunity. J. Leukoc. Biol. 88: 757-767.
50. Messal, N., E. Mamessier, A. Sylvain, J. Celis-Gutierrez, M. L. Thibult, B. Chetaille, G. Firaguay, S. Pastor, Y. Guillaume, Q. Wang, et al. 2011. Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. Eur. J. Immunol. 41: 3443-3454.
51. Simone, R., B. Barbarat, A. Rabellino, G. Icardi, M. Bagnasco, G. Pesce, D. Olive, and D. Saverino. 2010. Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. Mol. Immunol. 48: 109-118.
52. Smith, I. A., B. R. Knezevic, J. U. Ammann, D. A. Rhodes, D. Aw, D. B. Palmer, I. H. Mather, and J. Trowsdale. 2010. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 184: 3514-3525.
53. Yamazaki, T., I. Goya, D. Graf, S. Craig, N. Martin-Orozco, and C. Dong. 2010. A butyrophilin family member critically inhibits T cell activation. J. Immunol. 185: 5907-5914.
54. Nguyen, T., X. K. Liu, Y. Zhang, and C. Dong. 2006. BTNL2, a butyrophilinlike molecule that functions to inhibit T cell activation. J. Immunol. 176: 7354-7360.
55. Arnett, H. A., S. S. Escobar, E. Gonzalez-Suarez, A. L. Budelsky, L. A. Steffen, N. Boiani, M. Zhang, G. Siu, A. W. Brewer, and J. L. Viney. 2007. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 178: 1523-1533.
56. Bas, A., M. Swamy, L. Abeler-Dörner, G. Williams, D. J. Pang, S. D. Barbee, and A. C. Hayday. 2011. Butyrophilin-like 1 encodes an enterocyte protein that selectively regulates functional interactions with T lymphocytes. Proc. Natl. Acad. Sci. USA 108: 4376-4381.
57. Suntharalingam, G., M. R. Perry, S. Ward, S. J. Brett, A. Castello-Cortes, M. D. Brunner, and N. Panoskaltsis. 2006. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355: 1018-1028.
58. Beyersdorf, N., T. Hanke, T. Kerkau, and T. Hünig. 2005. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases. Ann. Rheum. Dis. 64(Suppl. 4): iv91-iv95.
59. Rhodes, D. A., B. de Bono, and J. Trowsdale. 2005. Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? Immunology 116: 411-417.
60. Perfetto, L., P. F. Gherardini, N. E. Davey, F. Diella, M. Helmer-Citterich, and G. Cesareni. 2013. Exploring the diversity of SPRY/B30.2-mediated interactions. Trends Biochem. Sci. 38: 38-46.
61. D'Cruz, A. A., J. J. Babon, R. S. Norton, N. A. Nicola, and S. E. Nicholson. 2013. Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity. Protein Sci. 22: 1-10.
62. Sardiello, M., S. Cairo, B. Fontanella, A. Ballabio, and G. Meroni. 2008. Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol. Biol. 8: 225.
63. James, L. C., A. H. Keeble, Z. Khan, D. A. Rhodes, and J. Trowsdale. 2007. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc. Natl. Acad. Sci. USA 104: 6200-6205.
64. Zhang, Z., M. Bao, N. Lu, L. Weng, B. Yuan, and Y.-J. Liu. 2013. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat. Immunol. 14: 172-178.
65. Biris, N., Y. Yang, A. B. Taylor, A. Tomashevski, M. Guo, P. J. Hart, F. Diaz-Griffero, and D. N. Ivanov. 2012. Structure of the rhesus monkey TRIM5a PRYSPRY domain, the HIV capsid recognition module. Proc. Natl. Acad. Sci. USA 109: 13278-13283.
66. Weinert, C., C. Grütter, H. Roschitzki-Voser, P. R. Mittl, and M. G. Grütter. 2009. The crystal structure of human pyrin b30.2 domain: implications for mutations associated with familial Mediterranean fever. J. Mol. Biol. 394: 226-236.
67. Filippakopoulos, P., A. Low, T. D. Sharpe, J. Uppenberg, S. Yao, Z. Kuang, P. Savitsky, R. S. Lewis, S. E. Nicholson, R. S. Norton, and A. N. Bullock. 2010. Structural basis for Par-4 recognition by the SPRY domain-And SOCS boxcontaining proteins SPSB1, SPSB2, and SPSB4. J. Mol. Biol. 401: 389-402.
68. Woo, J.-S., H.-Y. Suh, S.-Y. Park, and B.-H. Oh. 2006. Structural basis for protein recognition by B30.2/SPRY domains. Mol. Cell 24: 967-976.
69. Ohkura, S., M. W. Yap, T. Sheldon, and J. P. Stoye. 2006. All three variable regions of the TRIM5a B30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol. 80: 8554-8565.
70. Schnyder, B., D. Mauri-Hellweg, M. Zanni, F. Bettens, and W. J. Pichler. 1997. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human ab T cell clones. J. Clin. Invest. 100: 136-141.
71. Zanni, M. P., S. von Greyerz, B. Schnyder, T. Wendland, and W. J. Pichler. 1998. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific ab+ T cell clones. Int. Immunol. 10: 507-515.
72. Wu, Y., J. P. Sanderson, J. Farrell, N. S. Drummond, A. Hanson, E. Bowkett, N. Berry, A. V. Stachulski, S. E. Clarke, W. J. Pichler, et al. 2006. Activation of T cells by carbamazepine and carbamazepine metabolites. J. Allergy Clin. Immunol. 118: 233-241.
73. Zanni, M. P., S. von Greyerz, B. Schnyder, K. A. Brander, K. Frutig, Y. Hari, S. Valitutti, and W. J. Pichler. 1998. HLA-restricted, processing-And metabolism-independent pathway of drug recognition by human ab T lymphocytes. J. Clin. Invest. 102: 1591-1598.
74. Pichler, W. J., A. Beeler, M. Keller, M. Lerch, S. Posadas, D. Schmid, Z. Spanou, A. Zawodniak, and B. Gerber. 2006. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol. Int. 55: 17-25.
75. Hu, P., and B.-H. Luo. 2013. Integrin bi-directional signaling across the plasma membrane. J. Cell. Physiol. 228: 306-312.
76. Thompson, K., M. J. Rogers, F. P. Coxon, and J. C. Crockett. 2006. Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Mol. Pharmacol. 69: 1624-1632.
77. Boyden, L. M., J. M. Lewis, S. D. Barbee, A. Bas, M. Girardi, A. C. Hayday, R. E. Tigelaar, and R. P. Lifton. 2008. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gd T cells. Nat. Genet. 40: 656-662.
78. Barbee, S. D., M. J. Woodward, G. Turchinovich, J.-J. Mention, J. M. Lewis, L. M. Boyden, R. P. Lifton, R. Tigelaar, and A. C. Hayday. 2011. Skint-1 is a highly specific, unique selecting component for epidermal T cells. Proc. Natl. Acad. Sci. USA 108: 3330-3335.